Dempsey, E; Homfray, T; Simpson, JM; Jeffery, S; Mansour, S; Ostergaard, P
(2020)
Fetal hydrops – a review and a clinical approach to identifying the cause.
Expert Opinion on Orphan Drugs, 8 (2-3).
pp. 51-66.
ISSN 2167-8707
https://doi.org/10.1080/21678707.2020.1719827
SGUL Authors: Dempsey, Esther Alice
Preview |
|
PDF
Accepted Version
Available under License ["licenses_description_publisher" not defined].
Download (536kB)
| Preview
|
Abstract
Introduction: Fetal hydrops describes abnormal fluid accumulation in two or more extravascular fetal compartments. It is a poor prognostic sign in a fetus, and many will not survive to term. Fetal hydrops is a clinical sign rather than a diagnosis and has a multitude of different causes.
Areas covered: This review focusses on non-immune fetal hydrops. We discuss in detail the most common aetiologies such as infection and chromosomal abnormalities and cover rarer presentations of congenital malformation and single-gene disorders. We present a decision tree for the investigation of affected pregnancies.
Expert opinion: The current approach to the investigation of fetal hydrops largely revolves around identifying the abnormal pathophysiology via ultrasound imaging. We believe that as genomic testing of a pregnancy can be undertaken with increasing accuracy, speed, accessibility and at reduced cost, genetic testing will feature earlier in the future diagnostic pathway.
Statistics
Item downloaded times since 07 Feb 2020.
Actions (login required)
|
Edit Item |